ALX Oncology Holdings's market cap is currently ―. The company's EPS TTM is $-3.194; its P/E ratio is -1.50; ALX Oncology Holdings is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -33.79M	$ -29.80M	$ -32.45M	$ -36.68M	$ -33.79M
EBITDA	$ -34.86M	$ -30.33M	$ -32.55M	$ -36.59M	$ -33.70M
Net Income Common Stockholders	$ -34.16M	$ -30.18M	$ -30.71M	$ -35.32M	$ -32.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 212.84M	$ 227.94M	$ 266.21M	$ 284.91M	$ 313.37M
Total Assets	$ 245.93M	$ 278.14M	$ 306.49M	$ 317.69M	$ 346.02M
Total Debt	$ 9.51M	$ 9.45M	$ 9.39M	$ 6.60M	$ 1.07M
Net Debt	$ -203.32M	$ -218.49M	$ -256.82M	$ -278.31M	$ -312.29M
Total Liabilities	$ 33.24M	$ 37.75M	$ 43.02M	$ 30.73M	$ 29.70M
Stockholders Equity	$ 212.69M	$ 240.39M	$ 263.46M	$ 286.96M	$ 316.32M
Cash Flow	-
Free Cash Flow	$ -33.45M	$ -28.51M	$ -21.06M	$ -31.07M	$ -17.25M
Operating Cash Flow	$ -31.71M	$ -27.82M	$ -20.67M	$ -30.88M	$ -17.00M
Investing Cash Flow	$ 6.21M	$ 42.30M	$ 10.94M	$ 13.70M	$ -76.13M
Financing Cash Flow	$ 343.00K	$ -107.00K	$ 9.49M	$ -136.00K	$ 422.00K

Currency in USD

ALX Oncology Holdings Earnings and Revenue History

Income Statement >

ALX Oncology Holdings Debt to Assets

Balance Sheet >

ALX Oncology Holdings Cash Flow

Cash Flow >

ALX Oncology Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing